Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Hayman

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
JNCI Cancer Spectrum|July 1, 2024
Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivityThomas J Hayman
Cancer Metastasis Reviews|June 13, 2025
Role of PLK4 inhibition in cancer therapyKishore Banik, Thomas J Hayman
International Journal of Molecular Sciences|December 10, 2021
Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune MachineryThomas J Hayman, Peter M Glazer
Cancer Journal (Sudbury, Mass.)|September 27, 2022
STING Agonists in Head and Neck Squamous Cell CarcinomaDavid G Wallington, Joseph N Contessa, Thomas J Hayman
Molecular Cancer Therapeutics|April 29, 2025
PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivityIrma G Dominguez-Vigil, Kishore Banik, Marta Baro, et al.
Translational Oncology|June 5, 2013
Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell RadiosensitivityThomas J Hayman, Tamalee Kramp, Jenna Kahn, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivityIrma G Dominguez-Vigil, Kishore Banik, Marta Baro, et al.
Translational Cancer Research|February 4, 2022
Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative reviewThomas J Hayman, Aarti K Bhatia, Krishan R Jethwa, et al.
Cancer Research|March 9, 2012
Translation initiation factor eIF4E is a target for tumor cell radiosensitizationThomas J Hayman, Eli S Williams, Muhammad Jamal, et al.
Neuro-Oncology|December 7, 2013
The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cellsJenna Kahn, Thomas J Hayman, Muhammad Jamal, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
JNCI Cancer Spectrum|July 1, 2024
Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivityThomas J Hayman
Cancer Metastasis Reviews|June 13, 2025
Role of PLK4 inhibition in cancer therapyKishore Banik, Thomas J Hayman
International Journal of Molecular Sciences|December 10, 2021
Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune MachineryThomas J Hayman, Peter M Glazer
Cancer Journal (Sudbury, Mass.)|September 27, 2022
STING Agonists in Head and Neck Squamous Cell CarcinomaDavid G Wallington, Joseph N Contessa, Thomas J Hayman
Molecular Cancer Therapeutics|April 29, 2025
PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivityIrma G Dominguez-Vigil, Kishore Banik, Marta Baro, et al.
Translational Oncology|June 5, 2013
Competitive but Not Allosteric mTOR Kinase Inhibition Enhances Tumor Cell RadiosensitivityThomas J Hayman, Tamalee Kramp, Jenna Kahn, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
PLK4 inhibition as a strategy to enhance non-small cell lung cancer radiosensitivityIrma G Dominguez-Vigil, Kishore Banik, Marta Baro, et al.
Translational Cancer Research|February 4, 2022
Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative reviewThomas J Hayman, Aarti K Bhatia, Krishan R Jethwa, et al.
Cancer Research|March 9, 2012
Translation initiation factor eIF4E is a target for tumor cell radiosensitizationThomas J Hayman, Eli S Williams, Muhammad Jamal, et al.
Neuro-Oncology|December 7, 2013
The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cellsJenna Kahn, Thomas J Hayman, Muhammad Jamal, et al.
Pageof 2